Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
37 BRL | +8,00% | +0,87% | +14,55% |
Attività
Numero di dipendenti: 1 448
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 1 489 | 100,0 % | 1 887 | 100,0 % | +26,76% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 489 | 100,0 % | 1 887 | 100,0 % | +26,76% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01/01/92 |
Director of Finance/CFO | 44 | 01/11/17 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/11/21 |
Eiry Roberts
CTO | Chief Tech/Sci/R&D Officer | 60 | 08/01/18 |
Bill Wilson
COO | Chief Operating Officer | - | 01/09/96 |
Chief Tech/Sci/R&D Officer | 65 | 01/01/93 | |
Gary Lyons
BRD | Director/Board Member | 73 | 01/02/93 |
Todd Tushla
IRC | Investor Relations Contact | - | - |
Ingrid Delaet
LAW | General Counsel | 58 | 01/01/21 |
David Boyer
PRN | Corporate Officer/Principal | 44 | 30/09/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/04/99 |
George Morrow
BRD | Director/Board Member | 72 | 01/10/15 |
Kevin Gorman
FOU | Founder | 66 | 01/01/92 |
Christine Poon
BRD | Director/Board Member | 71 | 11/07/23 |
Chairman | 75 | 08/02/10 | |
Richard Pops
BRD | Director/Board Member | 62 | 01/04/98 |
Gary Lyons
BRD | Director/Board Member | 73 | 01/02/93 |
Leslie Norwalk
BRD | Director/Board Member | 58 | 01/04/98 |
Shalini Sharp
BRD | Director/Board Member | 49 | 03/02/20 |
Johanna Mercier
BRD | Director/Board Member | 54 | 15/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 100 637 227 | 98 821 809 ( 98,20 %) | 0 | 98,20 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. 15.77% | 8 575 316 | 15.77% | 72 032 654 $ |
Coordinate società
Neurocrine Biosciences, Inc.
6027 Edgewood Bend Court
92130, San Diego
+858 617 7600
http://www.neurocrine.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,49% | 122 Mrd | |
+21,73% | 116 Mrd | |
+22,18% | 27,03 Mrd | |
-21,81% | 20,36 Mrd | |
-16,89% | 16,43 Mrd | |
-18,81% | 15,91 Mrd | |
-44,74% | 15,6 Mrd | |
+62,72% | 14,94 Mrd | |
+122,59% | 11,24 Mrd |
- Borsa valori
- Azioni
- Azione NBIX
- Azione N1BI34
- Società Neurocrine Biosciences, Inc.